Vertex insider reports recent common‑share dispositions

Vertex Pharmaceuticals insider sale notice: A Form 144 submission lists proposed or recent dispositions of Common stock by Joy Liu.

Rhea-AI Filing Summary

Vertex Pharmaceuticals insider sale notice: A Form 144 submission lists proposed or recent dispositions of Common stock by Joy Liu. The excerpt shows three reported sales in the past three months: 03/02/2026 (892 shares, $442,396.32), 04/01/2026 (978 shares, $439,288.26), and 05/01/2026 (1,104 shares, $469,222.08). The filing also records an allocation of 828 shares tied to Restricted Stock Vesting dated 02/26/2025.

Insights

Securities Compliance Counsel

Form 144 reports recent dispositions by an affiliate rather than an issuer action.

The excerpt lists three past sales by Joy Liu with exact share counts and dollar amounts for March, April, and May 2026. It also records Restricted Stock Vesting of 828 shares dated 02/26/2025.

These entries reflect routine Section 144 disclosures that notify the market of affiliate disposals; the filing does not state whether sales were open‑market, pursuant to a trading plan, or the cash‑flow recipient beyond the reported dollar amounts.

Key Figures

Restricted Stock Vesting: 828 shares Sale on 03/02/2026: 892 shares Sale on 04/01/2026: 978 shares +1 more

4 metrics

Restricted Stock Vesting 828 shares vesting date <date>02/26/2025</date>

Sale on 03/02/2026 892 shares <money>$442,396.32</money>

Sale on 04/01/2026 978 shares <money>$439,288.26</money>

Sale on 05/01/2026 1,104 shares <money>$469,222.08</money>

Key Terms

Form 144, Restricted Stock Vesting, Securities To Be Sold

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Restricted Stock Vesting | Issuer | 828 | 02/26/2025"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 02/26/2025"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 for VRTX report?

The Form 144 reports proposed or recent dispositions of Common stock by Joy Liu. It lists three sales: 892 shares on 03/02/2026 ($442,396.32), 978 shares on 04/01/2026 ($439,288.26), and 1,104 shares on 05/01/2026 ($469,222.08).

Were any shares from restricted stock vesting reported?

Yes; the filing lists 828 shares tied to Restricted Stock Vesting dated 02/26/2025. The line appears under "Securities To Be Sold" with the method labeled "Restricted Stock Vesting" and the recipient listed as the issuer.

Do the Form 144 entries state how the sales were executed?

No; the excerpt does not specify execution methods. The filing provides dates, share counts, and dollar amounts but does not state whether sales were open‑market, block trades, or pursuant to a trading plan.

Who is the reporting person named in the excerpt?

The excerpt identifies Joy Liu as the individual associated with the reported sales. The entries include Joy Liu's address and the three sale dates with corresponding shares and dollar values for March, April, and May 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 02:13 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001847529
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	Liu Joy
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	828	364245.48	253805417	06/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/26/2025	Restricted Stock Vesting	Issuer			828	02/26/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Joy Liu 50 Northern Avenue Boston MA 02210	Common	03/02/2026	892	442396.32
Joy Liu 50 Northern Avenue Boston MA 02210	Common	04/01/2026	978	439288.26
Joy Liu 50 Northern Avenue Boston MA 02210	Common	05/01/2026	1104	469222.08

144: Remarks and Signature

Remarks
Date of Notice	06/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Tyler Johnson, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Joy Liu
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)